Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
51°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neogenomics Inc
(NQ:
NEO
)
15.30
+0.58 (+3.94%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neogenomics Inc
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
NeoGenomics' RaDaR Assay for Minimal Residual Disease Receives First Commercial Coverage
June 15, 2023
Via
ACCESSWIRE
NeoGenomics and German Breast Group Announce New Data Demonstrating Clinical Potential of the RaDaR MRD Assay in HR+/HER2- Breast Cancer
June 05, 2023
Via
ACCESSWIRE
NeoGenomics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference
June 01, 2023
Via
ACCESSWIRE
NeoGenomics to Showcase the Transformational Impact of RaDaR(R) Assay for Molecular Residual Disease and Recurrence Monitoring at ASCO
May 30, 2023
Via
ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
May 16, 2023
Via
Benzinga
NeoGenomics's Return On Capital Employed Insights
May 15, 2023
Via
Benzinga
NeoGenomics: Q1 Earnings Insights
May 12, 2023
Via
Benzinga
NeoGenomics Reports Q1 Topline Growth, Lifts Annual Guidance, Shares Soar
May 09, 2023
NeoGenomics Inc (NASDAQ: NEO) reported Q1 revenues of $137.22 mill
Via
Benzinga
Earnings Scheduled For May 12, 2023
May 12, 2023
Companies Reporting Before The Bell • Honda Motor Co (NYSE:HMC) is expected to report earnings for its fourth quarter.
Via
Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 09, 2023
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.
Via
Benzinga
Analyst Expectations for NeoGenomics's Future
May 09, 2023
Via
Benzinga
NeoGenomics Reports First Quarter 2023 Results
May 08, 2023
Via
ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2023
May 09, 2023
Via
Benzinga
McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday
May 09, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
NeoGenomics to Participate at the BofA Securities 2023 Healthcare Conference
May 03, 2023
Via
ACCESSWIRE
What 9 Analyst Ratings Have To Say About NeoGenomics
April 11, 2023
Via
Benzinga
Looking Into NeoGenomics's Return On Capital Employed
March 30, 2023
Via
Benzinga
Analyst Ratings for NeoGenomics
March 03, 2023
Via
Benzinga
Cowen & Co. Maintains Outperform Rating for NeoGenomics: Here's What You Need To Know
February 24, 2023
Via
Benzinga
NeoGenomics, Inc. (NASDAQ:NEO) Long Term Investor Alert: Investigation of Potential Wrongdoing
April 20, 2023
San Diego, CA -- (SBWIRE) -- 04/20/2023 -- An investigation concerning potential breaches of fiduciary duties by certain directors and officers of NeoGenomics, Inc was announced.
Via
SBWire
NeoGenomics to Announce First Quarter 2023 Financial Results
April 17, 2023
Via
ACCESSWIRE
NeoGenomics to Participate at the 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
Via
ACCESSWIRE
NeoGenomics to Share Nine Abstracts at the American Association of Cancer Research (AACR) Annual Meeting 2023
April 06, 2023
Via
ACCESSWIRE
NeoGenomics to Host Investor Day on April 4, 2023
March 27, 2023
Via
ACCESSWIRE
Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care
March 22, 2023
From
Massive Bio, Inc.
Via
Business Wire
3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing
March 19, 2023
The high-flyers have soared to new heights and further gains could be up ahead.
Via
The Motley Fool
NeoGenomics Announces Commercial Availability of the RaDaR(R) Molecular Residual Disease Test
March 16, 2023
Via
ACCESSWIRE
NeoGenomics Expands NGS Portfolio with Launch of Neo Comprehensive(TM) - Solid Tumor CGP and Neo Comprehensive(TM) - Myeloid Disorders CGP
March 13, 2023
Via
ACCESSWIRE
NeoGenomics to Present at the 44th Annual Raymond James Institutional Investors Conference
February 28, 2023
Via
ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
February 24, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.